TTN、OBSCN轴在结直肠癌肝转移中免疫功能临床进展
Clinical Progress of TTN and OBSCN Axes in Liver Metastasis of Colorectal Cancer
DOI: 10.12677/ACM.2023.133502, PDF,    科研立项经费支持
作者: 杜碧涟:大理大学临床医学院,云南 大理;谭云波, 金礼权*:大理大学第一附属医院普外一科,云南 大理
关键词: 结直肠癌肝转移TTN (Titin)OBSCNColorectal Cancer Liver Metastasis TTN (Titin) OBSCN
摘要: 结肠直肠癌(Colorectal Cancer, CRC)是我国最常见的恶性肿瘤之一,其发病率呈上升趋势。结直肠癌肝转移是患者主要死亡原因,但其分子机制尚未明确。近年来,免疫治疗在结直肠癌治疗中取得重大进展,但对于结直肠癌肝转移患者只有少部分人受益。TTN、OBSCN是常见的突变基因之一,他们的突变状态或可以作为免疫治疗的预测因子,本文将对TTN/OBSCN轴在结直肠癌肝转移中的免疫功能进行综述。
Abstract: Colorectal cancer (CRC) is one of the most common malignancies in China, and its incidence is on the rise. Colorectal cancer liver metastases are the leading cause of death in patients, but its molecular mechanism has not been defined. In recent years, immunotherapy has made significant progress in colorectal cancer treatment, but only a small number of patients with colorectal cancer liver metastases have benefited. TTN and OBSCN are one of the common mutant genes, their mutation status may be used as predictors of immunotherapy, this article will elaborate the immune function of TTN and OBSCN axis in colorectal cancer liver metastasis.
文章引用:杜碧涟, 谭云波, 金礼权. TTN、OBSCN轴在结直肠癌肝转移中免疫功能临床进展[J]. 临床医学进展, 2023, 13(3): 3510-3514. https://doi.org/10.12677/ACM.2023.133502

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Oaknin, A., Rubio, M.J., Redondo, A., et al. (2015) SEOM Guidelines for Cervical Cancer. Clinical and Translational Oncology, 17, 1036-1042. [Google Scholar] [CrossRef] [PubMed]
[3] Engstrand, J., Nilsson, H., Strömberg, C., Jonas, E. and Freedman, J. (2018) Colorectal Cancer Liver Metastases—A Population-Based Study on Incidence, Management and Survival. BMC Cancer, 18, Article No. 78. [Google Scholar] [CrossRef] [PubMed]
[4] Bhullar, D.S., Barriuso, J., Mullamitha, S., et al. (2019) Bi-omarker Concordance between Primary Colorectal Cancer and Its Metastases. eBioMedicine, 40, 363-374. [Google Scholar] [CrossRef] [PubMed]
[5] Van Huizen, N.A., Coebergh van den Braak, R.R.J., Doukas, M., et al. (2019) Up-Regulation of Collagen Proteins in Colorectal Liver Metastasis Compared with Normal Liver Tissue. Journal of Biological Chemistry, 294, 281-289. [Google Scholar] [CrossRef
[6] 中国结直肠癌肝转移诊断和综合治疗指南(2020版) [J]. 临床肝胆病杂志, 2021, 37(3): 543-553.
[7] Ganesh, K., Stadler, Z.K., Cercek, A., et al. (2019) Immunotherapy in Colo-rectal Cancer: Rationale, Challenges and Potential. Nature Reviews Gastroenterology & Hepatology, 16, 361-375. [Google Scholar] [CrossRef] [PubMed]
[8] Kather, J.N., Halama, N. and Jaeger, D. (2018) Genomics and Emerging Biomarkers for Immunotherapy of Colorectal Cancer. Seminars in Cancer Biology, 52, 189-297. [Google Scholar] [CrossRef] [PubMed]
[9] Deshmukh, A.S., Murgia, M., Nagaraj, N., et al. (2015) Deep Proteomics of Mouse Skeletal Muscle Enables Quantitation of Protein Isoforms, Metabolic Pathways, and Tran-scription Factors. Molecular & Cellular Proteomics, 14, 841-853. [Google Scholar] [CrossRef
[10] Murphy, S. and Ohlendieck, K. (2018) Proteomic Profiling of Large Myofibrillar Proteins From Dried and Long-Term Stored Polyacrylamide Gels. Analytical Biochemistry, 543, 8-11. [Google Scholar] [CrossRef] [PubMed]
[11] Murgia, M., Nagaraj, N., Deshmukh, A.S., et al. (2015) Single Muscle Fiber Proteomics Reveals Unexpected Mitochondrial Specialization. EMBO Reports, 16, 387-395. [Google Scholar] [CrossRef] [PubMed]
[12] Savarese, M., Maggi, L., Vihola, A., et al. (2018) Interpreting Genetic Variants in Titin in Patients with Muscle Disorders. JAMA Neurology, 75, 557-565. [Google Scholar] [CrossRef] [PubMed]
[13] Cao, X., Liu, B., Cao, W., et al. (2013) Autophagy Inhibition Enhances Apigenin-Induced Apoptosis in Human Breast Cancer Cells. Chinese Journal of Cancer Research, 25, 212-222.
[14] Jia, Q., Wang, J., He, N., Hem J. and Zhu, B. (2019) Titin Mutation Associated with Responsiveness to Checkpoint Blockades in Solid Tumors. JCI Insight, 4, e127901. [Google Scholar] [CrossRef] [PubMed]
[15] Wang, Z., Wang, C., Lin, S. and Yu, X. (2021) Effect of TTN Mutations on Immune Microenvironment and Efficacy of Immunotherapy in Lung Adenocarcinoma Patients. Frontiers in Oncology, 11, Article ID: 725292. [Google Scholar] [CrossRef] [PubMed]
[16] Manring, H.R., Carter, O.A. and Ackermann, M.A. (2017) Obscure Functions: The Location-Function Relationship of Obscurins. Biophysical Reviews, 9, 245-258. [Google Scholar] [CrossRef] [PubMed]
[17] Tskhovrebova, L. and Trinick, J. (2017) Titin and Nebulin in Thick and Thin Filament Length Regulation. In: Parry, D. and Squire, J., Eds., Fibrous Proteins: Structures and Mechanisms. Subcellular Biochemistry, Vol. 82, Springer, Cham, 285-318. [Google Scholar] [CrossRef] [PubMed]
[18] Russell, M.W., Raeker, M.O., Korytkowski, K.A. and Sonneman, K.J. (2002) Identification, Tissue Expression and Chromosomal Localization of Human Obscurin-MLCK, a Member of the Titin and Dbl Families of Myosin Light Chain Kinases. Gene, 282, 237-246. [Google Scholar] [CrossRef
[19] Perry, N.A., Ackermann, M.A., Shriver, M., Hu, L.-Y.R. and Kontrogianni-Konstantopoulos, A. (2013) Obscurins: Unassuming Giants Enter the Spotlight. IUBMB Life, 65, 479-486. [Google Scholar] [CrossRef] [PubMed]
[20] Sjöblom, T., Jones, S., Wood, L.D., et al. (2006) The Consensus Coding Sequences of Human Breast and Colorectal Cancers. Science, 314, 268-274. [Google Scholar] [CrossRef] [PubMed]
[21] Babur, Ö., Gönen, M., Aksoy, B.A., et al. (2015) Systematic Iden-tification of Cancer Driving Signaling Pathways Based on Mutual Exclusivity of Genomic Alterations. Genome Biology, 16, Article No. 45. [Google Scholar] [CrossRef] [PubMed]
[22] Murphy, S.J., Hart, S.N., Lima, J.F., et al. (2013) Genetic Alter-ations Associated with Progression from Pancreatic Intraepithelial Neoplasia to Invasive Pancreatic Tumor. Gastroen-terology, 145, 1098-109. [Google Scholar] [CrossRef] [PubMed]
[23] Shriver, M., Stroka, K.M., Vitolo, M.I., et al. (2015) Loss of Giant Obscurins from Breast Epithelium Promotes Epithelial-to-Mesenchymal Transition, Tumorigenicity and Metastasis. Oncogene, 34, 4248-4259. [Google Scholar] [CrossRef] [PubMed]
[24] Alves, J.M., Prado-López, S., Cameselle-Teijeiro, J.M. and Posada, D. (2019) Rapid Evolution and Biogeographic Spread in a Colorectal Cancer. Nature Communications, 10, Article No. 5139. [Google Scholar] [CrossRef] [PubMed]
[25] Neidhardt, J., Fehr, S., Kutsche, M., Löhler, J. and Schachner, M. (2003) Tenascin-N: Characterization of a Novel Member of the Tenascin Family That Mediates Neurite Repulsion from Hippocampal Explants. Molecular and Cellular Neuroscience, 23, 193-209. [Google Scholar] [CrossRef
[26] Wang, X., Duanmu, J., Fu, X., Li, T. and Jiang, Q. (2020) Analyzing and Validating the Prognostic Value and Mechanism of Colon Cancer Immune Microenvironment. Journal of Translational Medicine, 18, Article No. 324. [Google Scholar] [CrossRef] [PubMed]
[27] Cheng, X., Yin, H., Fu, J., et al. (2019) Aggregate Analysis Based on TCGA: TTN Missense Mutation Correlates with Favorable Prognosis in Lung Squamous Cell Carcinoma. Journal of Cancer Research and Clinical Oncology, 145, 1027-1035. [Google Scholar] [CrossRef] [PubMed]
[28] Yi, H., Liao, Z.-W., Chen, J.-J., et al. (2021) Genome Variation in Colorectal Cancer Patient with Liver Metastasis Measured by Whole-Exome Sequencing. Journal of Gastrointestinal Oncology, 12, 507-515. [Google Scholar] [CrossRef] [PubMed]